ERNA - Eterna Therapeutics Inc
Eterna Therapeutics Inc Logo

ERNA - Eterna Therapeutics Inc

https://www.ernexatx.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.

52W High
$24.15
52W Low
$1.21
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
6.74
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.29
EV/Revenue (<3 favorable)
12.10
P/S (TTM) (<3 favorable)
19.73
P/B (<3 favorable)
2.17
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
59.71%
Institutions (25–75% balanced)
0.65%
Shares Outstanding
7,670,900
Float
3,157,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
488,000
Gross Profit (TTM)
548,000
EPS (TTM)
-17.76
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-24.10%
ROE (TTM) (>15% strong)
-22.64%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.94
Momentum
Bearish momentum
Value
-0.1332
Previous
-0.1390
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025